Travere prices upsized $275 million convertible senior notes offering

San diego, march 08, 2022 (globe newswire) -- travere therapeutics, inc. (nasdaq: tvtx) today announced the pricing of its underwritten offering of $275 million aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”). the sale of the notes is expected to close on march 11, 2022, subject to customary closing conditions. the aggregate principal amount of the offering was increased from the previously announced offering size of $250 million. travere also granted the underwriters of the notes an option to purchase, for settlement on or before march 31, 2022, up to an additional $41.25 million aggregate principal amount of notes, solely to cover over-allotments.
TVTX Ratings Summary
TVTX Quant Ranking